AHM-510 Exam Dumps | The Good & Well Pharmacy, a Medicaid provider of outpatient drugs, is subject to the prospective

<< Prev Question Next Question >>

Question 7/45

The Good & Well Pharmacy, a Medicaid provider of outpatient drugs, is subject to the prospective drug utilization review (DUR) mandates of the Omnibus Budget Reconciliation Act of 1990 (OBRA '90). One component of prospective DUR is screening. In this context, when Good & Well is involved in the process of screening, the pharmacy is

A. Reviewing patient profiles for the purpose of identifying potential problems

B. Updating a formulary to represent the current clinical judgment of providers and experts in the diagnosis and treatment of disease

C. Denying coverage for the off-label use of approved drugs

D. Consulting directly with prescribers and patients in the planning of drug therapy

Question 7/45

LEAVE A REPLY

Download PDF File